ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 87 filers reported holding ARATANA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,898,000 | +10.9% | 775,000 | -3.1% | 0.01% | +8.3% |
| Q1 2016 | $4,416,000 | -1.1% | 800,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $4,464,000 | -24.6% | 800,000 | +14.3% | 0.01% | -25.0% |
| Q3 2015 | $5,922,000 | -62.7% | 700,000 | -33.3% | 0.02% | -60.0% |
| Q2 2015 | $15,876,000 | -17.4% | 1,050,000 | -12.5% | 0.04% | -14.9% |
| Q1 2015 | $19,212,000 | -17.1% | 1,200,000 | -7.7% | 0.05% | -17.5% |
| Q4 2014 | $23,166,000 | +46.5% | 1,300,000 | -17.5% | 0.06% | +46.2% |
| Q3 2014 | $15,813,000 | -20.5% | 1,575,000 | +23.5% | 0.04% | -23.5% |
| Q2 2014 | $19,903,000 | -15.9% | 1,275,000 | 0.0% | 0.05% | -21.5% |
| Q1 2014 | $23,664,000 | -2.8% | 1,275,000 | 0.0% | 0.06% | +1.6% |
| Q4 2013 | $24,353,000 | +49.0% | 1,275,000 | +27.5% | 0.06% | +36.2% |
| Q3 2013 | $16,340,000 | +116.1% | 1,000,000 | 0.0% | 0.05% | +104.3% |
| Q2 2013 | $7,560,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 218,515 | $1,219,000 | 11.21% |
| Broadfin Capital, LLC | 3,428,865 | $19,133,000 | 1.18% |
| MPM ASSET MANAGEMENT LLC | 1,117,875 | $6,238,000 | 1.11% |
| AlpInvest Partners B.V. | 100,001 | $558,000 | 0.93% |
| First Light Asset Management, LLC | 395,043 | $2,204,000 | 0.92% |
| Westend Capital Management, LLC | 89,780 | $501,000 | 0.69% |
| Grandeur Peak Global Advisors, LLC | 460,675 | $2,571,000 | 0.53% |
| AWM Investment Company, Inc. | 467,507 | $2,609,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 111,705 | $623,000 | 0.27% |
| Sio Capital Management, LLC | 97,376 | $543,000 | 0.24% |